KrishnanM., ThodisE., IkonomopoulosD., VigdenE., ChuM., BargmanJ.M.Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Perit Dial Int2002; 22: 563–5.
2.
FriedL.F., BernardiniJ., JohnstonJ.R., PirainoB.Peritonitis influences mortality in peritoneal dialysis patients.J Am Soc Nephrol1996; 7: 2176–82.
3.
United States Renal Data System.USRDS 2004 Annual Data Report.Bethesda, MD: National Institutes of Heath, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
4.
MendelssohnD.C., LangloisN., BlakeP.C.Peritoneal dialysis in Ontario: A natural experience in physician reimbursement methodology.Perit Dial Int2004; 24: 531–7.
5.
MettangT.Changes in dialysis reimbursement regulations in Germany.Perit Dial Int2004; 24: 526–7.
6.
LittleJ., IrwinA., MarshallT., RaynerH., SmithS.Predicting a patient's choice of dialysis modality: Experience in a United Kingdom renal department.Am J Kidney Dis2001; 37: 981–6.
7.
JassalS.V., KrishnaG., MallickN.P., MendelssohnD.C.Attitudes of British Isles nephrologists towards dialysis modality selection: A questionnaire study.Nephrol Dial Transplant2002; 17: 474–7.
8.
MendelssohnD.C., MullaneyS.R., JungB., BlakeP., MehtaR.L.What do American nephrologists think about dialysis modality selection?Am J Kidney Dis2001; 37: 22–9.
9.
JungB., BlakeP., MehtaR.L., MendelssohnD.C.Attitudes of Canadian nephrologists toward dialysis modality selection.Perit Dial Int1999; 19: 263–8.
10.
TroidleL., KligerA.S., FinkelsteinF.O.Factors influencing CPD utilization in Network #1: New England [Abstract].J Am Soc Nephrol2004; 15: 354A.
11.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Differing outcomes of gram-positive and gram-negative peritonitis.Am J Kidney Dis1998; 32: 623–8.
12.
Gorban-BrennanN., TroidleL., KligerA.S., FinkelsteinF.O.Peritonitis and its relationship with death in a large CPD cohort [Abstract].Perit Dial Int1999; 19(Suppl 1): S31.
13.
JuergensenP.J., MurphyA.L., KligerA.S., FinkelsteinF.O.Increasing the dialysis volume and frequency in a fixed period of time in CPD patients: The effect on Kpt/V and creatinine clearance.Perit Dial Int2002; 22: 693–7.
14.
Gorban-BrennanN., KligerA., FinkelsteinF.Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.Adv Perit Dial1999; 15: 213–16.
YishakA., BernardiniJ., FriedL., PirainoB.The outcome of peritonitis in patients on automated peritoneal dialysis.Adv Perit Dial2001; 17: 205–8.
17.
BrownE.A., DaviesS.J., RutherfordP., MeeusF., RiegelW., Divino-FilhoJ.C.; EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study.J Am Soc Nephrol2003; 14: 2948–57.
18.
LyeW.C., van der StraatenJ.C., LeongS.O., SivaramanP., TanS.H., TanC.C.Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.Perit Dial Int1999; 19: 357–60.
19.
ManleyH.J., BailieG.R., AsherR.D., EiseleG., FryeR.F.Pharmacokinetics of intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 65–70.
20.
WongK.M., ChanY.H., CheungC.Y., ChakW.L., ChoiK.S., LeungS.H.Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.Am J Kidney Dis2001; 38: 127–31.
21.
VasS.I.Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis.Perit Dial Int1993; 13(Suppl 2): S355–6.
22.
MorseG.D., FarolinoD.F., ApicellaM.A., WalsheJ.J.Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1987; 31: 173–7.
ManleyH.J., BailieG.R., FryeR., HessL.D., McGoldrickM.D.Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.J Am Soc Nephrol2000; 11: 1310–16.
25.
ElwellR.J., ManleyH.J., BailieG.R.Comparison of intraperitoneal ceftazidime pharmacokinetics in CAPD and APD patients [Abstract].J Am Soc Nephrol2002; 13: 383A.
26.
YeungS.M., WalkerS.E., TailorS.A.N., AwdishuL., TobeS., YassaT.Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.Perit Dial Int2004; 24: 447–53.
27.
FieldingR.E., ClemengerM., GoldbergL., BrownE.A.Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.Perit Dial Int2002; 22: 345–9.
28.
GoldbergL., ClemengerM., AzadianB., BrownE.A.Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.Am J Kidney Dis2001; 37: 49–55.
29.
CostertonJ.W., StewartP.S., GreenbergE.P.Bacterial biofilms: A common cause of persistent infections.Science1999; 284: 1318–22.
30.
CostertonW., VeehR., ShirtliffM., PasmoreM., PostC., EhrlichG.The application of biofilm science to the study and control of chronic bacterial infections.J Clin Invest2003; 112: 1466–77.
31.
SepandjF., CeriH., GibbA.P., ReadR.R., OlsonM.Biofilm infections in peritoneal dialysis-related peritonitis: Comparison of standard MIC and MBEC in evaluation of antibiotic sensitivity of coagulase-negative staphylococci.Perit Dial Int2003; 23: 77–9.
32.
SepandjF., CeriH., GibbA., ReadR., OlsonM.Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis.Perit Dial Int2004; 24: 65–7.
33.
KhaledG.H., FinkelsteinF.O., CareyH.B., WardlawS.C., KligerA.S., EdbergS.C.Method for studying development of colonization and infection of dialysis catheters.Adv Perit Dial2001; 17: 163–71.
34.
TroidleL., Gorban-BrennanN., KhaledG.H., EdbergS.C., FinkelsteinF.O.Biofilm and its clinical significance [Abstract].Perit Dial Int2002; 22(Suppl 1): S41.
35.
DasguptaM.K.Biofilms and infection in dialysis patients.Semin Dial2002; 15: 338–46.
36.
FinkelsteinE.S., JekelJ., TroidleL., Gorban-BrennanN., FinkelsteinF.O., BiaF.J.Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis.Am J Kidney Dis2002; 39: 1278–86.
